Responding to a series of infections connected to inadequately sterilized duodenoscopes, the FDA on Tuesday released a set of "supplemental reprocessing measures" aimed at minimizing the risk of residual pathogens on these devices.
Responding to a series of infections connected to inadequately sterilized duodenoscopes, the FDA on Tuesday released a set of "supplemental reprocessing measures" aimed at minimizing the risk of residual pathogens on these devices.